Skip navigation
Speakers

Innovative Models for Assurance and Advisory Practices

October 2-4, 2019
  • Philadelphia, PA

Philippe Attias
Chief Audit Executive, Vice President of Internal Audit
Vertex Pharmaceuticals

Richard Bistrong
CEO, Front-Line Anti-Bribery LLC;
former FCPA Violator and FBI/UK Cooperator

Michael Briganti
Director, International Business Controls Function Lead
Bristol-Myers Squibb

Vicky Cheng
Life Sciences Managing Director
Crowe LLP

Wetonia Evans CPA, CIA, CFE
Director, Business Risk and Compliance
GlaxoSmithKline (GSK)

Sheila Faella, CCEP
Senior Manager, North America Testing & Monitoring Services
Johnson & Johnson

Michelle Hayes, CPA, CIA, CISA, PMP
Director, Financial Controls and Compliance
GlaxoSmithKline (GSK)

Pierre Helfer
Vice President, Head of Internal Audit & Risk Management
Indivior Inc.

Marie Hendrixson
Vice President, Internal Audit
Teleflex

Vincent Hom
Partner, Forensic & Integrity Services
Ernst & Young LLP

Rachael Honig
First Assistant U.S. Attorney
U.S. Attorney’s Office for the District of New Jersey

Franco Kakiko
Director, Internal Audit
Daiichi Sankyo Inc.

Kera Kiernan
Senior Account Executive
Oversight Systems

Rahul Khara, PharmD
Senior Director, Compliance and Commercial Counsel
Acceleron Pharma Inc.

Jim Koenig
Partner, Global Co-Chair, Privacy and Cybersecurity Practice
Fenwick & West

Richard Konzelmann
Lead US Risk Assessment and Compliance Audit
Sanofi

Holly Kramen
Chief Compliance Officer and Privacy Officer
PolarityTE, Inc.

Ryan Lenz
Vice President, Head of Europe, Middle East,
Africa and Asia Audit and Assurance
GlaxoSmithKline (Invited)

Stephanie Lewko
Director, Life Sciences Governance,
Risk Management and Compliance
Navigant

Adam Marshall
Director, Risk Advisory Services
RSM LLP

Greg Naviloff
New England Practice Leader
RSM US LLP

Chris Palermo
Chief Audit Executive and Vice President, Internal Audit
Endo Pharmaceuticals

Mark Pearson
Principal
Deloitte

Roberta Rima
Associate Director of Internal Audit
Gilead

Nate Ruey
Partner, Risk Advisory Services
RSM US LLP

Joseph Sacchetti,CPA
Audit Manager
AstraZeneca

Harold Silverman
Managing Director of CAE Services
The Institute of Internal Auditors (IIA)

Amanda Strachan
Chief, Health Care Fraud Unit
U.S. Attorney’s Office for the District of Massachusetts

Alexis Stroud
Director, Ethics & Compliance, Auditing,
Monitoring and Risk Assessment
Boehringer Ingelheim

Seth B. Whitelaw
Editor
Policy & Medicine Compliance Update

Philippe Attias
Chief Audit Executive, Vice President of Internal Audit
Vertex Pharmaceuticals

Richard Bistrong
CEO, Front-Line Anti-Bribery LLC;
former FCPA Violator and FBI/UK Cooperator

Michael Briganti
Director, International Business Controls Function Lead
Bristol-Myers Squibb

Vicky Cheng
Life Sciences Managing Director
Crowe LLP

Wetonia Evans CPA, CIA, CFE
Director, Business Risk and Compliance
GlaxoSmithKline (GSK)

Sheila Faella, CCEP
Senior Manager, North America Testing & Monitoring Services
Johnson & Johnson

Michelle Hayes, CPA, CIA, CISA, PMP
Director, Financial Controls and Compliance
GlaxoSmithKline (GSK)

Pierre Helfer
Vice President, Head of Internal Audit & Risk Management
Indivior Inc.

Marie Hendrixson
Vice President, Internal Audit
Teleflex

Vincent Hom
Partner, Forensic & Integrity Services
Ernst & Young LLP

Rachael Honig
First Assistant U.S. Attorney
U.S. Attorney’s Office for the District of New Jersey

Franco Kakiko
Director, Internal Audit
Daiichi Sankyo Inc.

Kera Kiernan
Senior Account Executive
Oversight Systems

Rahul Khara, PharmD
Senior Director, Compliance and Commercial Counsel
Acceleron Pharma Inc.

Jim Koenig
Partner, Global Co-Chair, Privacy and Cybersecurity Practice
Fenwick & West

Richard Konzelmann
Lead US Risk Assessment and Compliance Audit
Sanofi

Holly Kramen
Chief Compliance Officer and Privacy Officer
PolarityTE, Inc.

Ryan Lenz
Vice President, Head of Europe, Middle East,
Africa and Asia Audit and Assurance
GlaxoSmithKline (Invited)

Stephanie Lewko
Director, Life Sciences Governance,
Risk Management and Compliance
Navigant

Adam Marshall
Director, Risk Advisory Services
RSM LLP

Greg Naviloff
New England Practice Leader
RSM US LLP

Chris Palermo
Chief Audit Executive and Vice President, Internal Audit
Endo Pharmaceuticals

Mark Pearson
Principal
Deloitte

Roberta Rima
Associate Director of Internal Audit
Gilead

Nate Ruey
Partner, Risk Advisory Services
RSM US LLP

Joseph Sacchetti,CPA
Audit Manager
AstraZeneca

Harold Silverman
Managing Director of CAE Services
The Institute of Internal Auditors (IIA)

Amanda Strachan
Chief, Health Care Fraud Unit
U.S. Attorney’s Office for the District of Massachusetts

Alexis Stroud
Director, Ethics & Compliance, Auditing,
Monitoring and Risk Assessment
Boehringer Ingelheim

Seth B. Whitelaw
Editor
Policy & Medicine Compliance Update